Form4insider filings, from the source

SEC Form 4 · accession 0001179110-15-006391

KYTHERA BIOPHARMACEUTICALS INC · KYTH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Keith R Leonard
Officer — President & CEO · Director
Period of report
Apr 15, 2015
Accepted (ET)
Apr 17, 2015 · 1:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001436304

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF7,F2Apr 15, 2015S1,500$50.402D859,190ISee footnote
Common StockF8,F9,F2Apr 15, 2015S1,209$50.675D863,073ISee footnote
Common StockF9,F3holding———47,103ISee footnote
Common StockF9,F4holding———47,103ISee footnote
Common StockF5holding———189ISee footnote
Common StockF6holding———189ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses